Description

1-[4-Chloro-2-(2-Chlorobenzoyl)Phenyl]-5-(Morpholinomethyl)-1H-1,2,4-Triazole-3-Carboxylic Acid Monohydrochloride is a high-purity, complex organic intermediate of significant importance in advanced pharmaceutical synthesis. This compound matters for its role as a critical building block in the development of active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated heterocyclic chemistry. It is primarily needed by research institutions, custom synthesis houses, and pharmaceutical manufacturers engaged in the development of novel drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex active pharmaceutical ingredients (APIs) and drug candidates.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the discovery of new therapeutic agents.
• Custom Synthesis: Serves as a specialized building block for contract research organizations (CROs) and CDMOs (Contract Development and Manufacturing Organizations).
• Chemical Biology: Potential use as a probe or tool compound in biochemical and pharmacological research due to its specific molecular scaffold.
• Agrochemical Research: May be investigated as an intermediate for novel crop protection agents, given the bioactivity of triazole derivatives.

Basic Information

Product Name	1-[4-Chloro-2-(2-Chlorobenzoyl)Phenyl]-5-(Morpholinomethyl)-1H-1,2,4-Triazole-3-Carboxylic Acid Monohydrochloride
CAS No.	67935-96-0
Molecular Formula	C21H19Cl2N5O4 • HCl
Molecular Weight	516.77 g/mol
Synonyms	1-[4-Chloro-2-(2-chlorobenzoyl)phenyl]-5-(morpholin-4-ylmethyl)-1H-1,2,4-triazole-3-carboxylic acid hydrochloride; 1-[4-Chloro-2-(2-chlorobenzoyl)phenyl]-5-(morpholinomethyl)-1H-1,2,4-triazole-3-carboxylic acid HCl; 1H-1,2,4-Triazole-3-carboxylic acid, 1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-(morpholinomethyl)-, monohydrochloride; 67935-96-0; UNII-9Q6K8J1Q8F; 9Q6K8J1Q8F
EINECS	Contact for details

Quality Control

Our 1-[4-Chloro-2-(2-Chlorobenzoyl)Phenyl]-5-(Morpholinomethyl)-1H-1,2,4-Triazole-3-Carboxylic Acid Monohydrochloride is manufactured under strict quality management systems. The product undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing batch-specific results are available upon request, supporting compliance with cGMP standards for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.